Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study

European Journal of Haematology

Volumn 56, Issue 1-2, 1996, Pages 45-53

  Ribatti, D ^a,b   Vacca, A ^a   Nico, B ^a   Fanelli, M ^a   Roncali, L ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Angiogenesis; B cell non Hodgkin's lymphoma; Laminin; Tumor progression; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; LAMININ;

ADULT; AGED; ANGIOGENESIS; ARTICLE; B CELL LYMPHOMA; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STROMA;

EID: 0029995264     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb00293.x     Document Type: Article

References (33)

1. RISAU W, LEMMON V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Devl Biol 1988: 125: 441-450.
2. PAKU S, PAWELETZ N. First steps of tumor-related angiogenesis. Lab Invest 1991: 65: 334-346.
3. AUSPRUNK DH, FOLKMAN J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977: 14: 53-65.
4. CAREY DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Ann Rev Physiol 1991: 53: 161-177.
5. FOLKMAN J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990: 82: 4-6.
6. WEINSTATSASLOW D, STEEG PS. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 1994: 8: 401-407.
7. THE NON-HODGKIN'S LYMPHOMA PATHOLOGIC CLASSIFICATION PROJECT. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982: 49: 2112-2135.
8. WAIN SL, BRAYLAN RC, BOROWITZ MJ. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience. Cancer 1987: 60: 2403-2411.
9. DIAMOND LW, MATHWANI BN, RAPPAPORT H. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 1982: 50: 1122-1135.
10. JOENSUU H, KLEMI PJ, JALKANEN S. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study. Cancer 1990: 65: 2564-2571.
11. CARBONE PP, KAPLAN HS, MUSSHOF K, SMITHERS DW, TUBIANA M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971: 31: 1860-1861.
12. IOACHIM AL. Lymph Node Pathology. 2nd Edition. Philadelphia: JB Lippincott Company, 1994.
13. VACCA A, RANIERI G, RIBATTI D, et al. Differential expression of two ICAM-1 epitopes and LFA-1 chains in B cell non-Hodgkin's lymphomas. Eur J Haematol 1994: 53: 85-92.
14. ELIAS H, HYDE DM. Stereological measurements of isotropic structures. In: ELIAS H, HYDE DM, eds. A Guide to Practical Stereology, Basel: Karger, 1983: 25: 25-44.
15. VACCA A, RIBATTI D, RONCALI L, et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993: 72: 455-461.
16. FOLKMAN J, WATSON K, INGBER D, HANAHAN D. Induction of angiogenesis during transition from hyperplasia to neoplasia. Nature 1989: 339: 58-61.
17. VACCA A, RIBATTI D, RONCALI L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994: 87: 503-508.
18. HOLTE H, LANGE DAVIS C, BEISKE K, et al. Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumor progression in low-grade B-cell lymphoma. Int J Cancer 1989: 44: 975-980.
19. HAYES DF. Angiogenesis and breast cancer. Hematol Oncol Clin N Am 1994: 8: 51-72.
20. MACCHIARINI P, FONTANINI G, HARDIN MJ, SQUARTINI, ANGELETTI CA. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 1992: 340: 145-146.
21. WEIDNER N, CARROL PR, FLAX J, BLUMENFELD W, FOLKMAN J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993: 143: 401-409.
22. KLAGSBRUN M, D'AMORE PA. Regulators of angiogenesis. Ann Rev Physiol 1991: 53: 217-239.
23. FRANCIA DI CELLE P, CARBONE A, MARCHIS D, et al. Cytokine gene expression in B-cell lymphocytic leukemia: evidence of constitutive IL-8 mRNA expression and secretion of biologically active IL-8 protein. Blood 1994: 84: 220-228.
24. KOCH AE, POLVERINI PJ, KUNKEL SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992: 258: 1178-1181.
25. VACCA A, RIBATTI D, RONCALI L, DAMMACCO F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymph 1995 (in press).
26. REILLY JI, NASH JR, MACKIE MJ, MCVERRY BA. Distribution of fibronectin and laminin in normal and pathological lymphoid tissue. J Clin Pathol 1985: 38: 849-854.
27. CARBONE A, MANCONI R, POLETTI A, et al. S-100 protein, fibronectin and laminin immunostaining in lymphomas of follicular center cell origin. Cancer 1986: 58: 2169-2176.
28. FURCHT LT. Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest 1986: 55: 505-509.
29. MIETTINEN M, LINDENMAYER AE, CHAUBAL A. Endothelial cell markers CD31, CD34 and BNH9 antibody to H-and Y-antigens. Evaluation of their specificity and sensitivity in the diagnosis of vascular tumours and comparison with von Willebrand factor. Modern Pathol 1994: 7: 82-90.
30. WAGNER RG. Endothelial cell embryology and growth. Adv Microcirc 1980: 9: 45-75.
31. NICOSIA RF, TCHAO R, LEIGHTON J. Histiotypic angiogenesis in vitro: light microscopic, ultrastructural and autoradiographic studies. In Vitro 1982: 18: 538-549.
32. DVORAK HF, HARVEY VS, ESTRELLA P, BROWN L, MCDONACH J, DVORAK AM. Fibrin containing gels induced angiogenesis. Implication for tumor stroma generation and wound healing. Lab Invest 1987: 57: 673-86.
33. BARCLAY AN, BIRKELAND ML, BROWN MH, et al. eds. The Leukocyte Antigens. London: Facts Book, Academic Press, 1993.